MARKER THERAPEUTICS, INC. Loans and Leases Receivable, Gross, Commercial (Deprecated 2016-01-31)
MARKER THERAPEUTICS, INC. (MRKR) had Loans and Leases Receivable, Gross, Commercial (Deprecated 2016-01-31) of -$23.00 thousand as of 2015-12-31, per its 10-K filed 2016-04-14.
Discontinued › Notes › Leases
us-gaap:LoansAndLeasesReceivableCommercial · last filed 2016-04-14
- 2015-12-31: Loans and Leases Receivable, Gross, Commercial (Deprecated 2016-01-31) -$23.00K.
- 2014-12-31: Loans and Leases Receivable, Gross, Commercial (Deprecated 2016-01-31) -$23.00K; Loans and Leases Receivable, Gross, Commercial (Deprecated 2016-01-31) as first filed -$52.94K.
- 2014-09-30: Loans and Leases Receivable, Gross, Commercial (Deprecated 2016-01-31) -$52.94K.
- 2014-06-30: Loans and Leases Receivable, Gross, Commercial (Deprecated 2016-01-31) -$67.94K.
| Period end | Loans and Leases Receivable, Gross, Commercial (Deprecated 2016-01-31) | Loans and Leases Receivable, Gross, Commercial (Deprecated 2016-01-31) as first filed |
|---|---|---|
| 2015-12-31 | -$23.00K 10-K · filed 2016-04-14 | |
| 2014-12-31 | -$23.00K 10-K · filed 2016-04-14 | -$52.94K 10-K · filed 2015-04-15 |
| 2014-09-30 | -$52.94K 10-Q · filed 2014-11-19 | |
| 2014-06-30 | -$67.94K 10-Q · filed 2014-08-18 | |
| 2013-12-31 | -$277.94K 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |